1. Home
  2. ENVX vs NUVB Comparison

ENVX vs NUVB Comparison

Compare ENVX & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$9.06

Market Cap

2.4B

Sector

Miscellaneous

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.62

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
NUVB
Founded
2006
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENVX
NUVB
Price
$9.06
$8.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$17.14
$9.63
AVG Volume (30 Days)
6.5M
10.2M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,273,000.00
$26,748,000.00
Revenue This Year
$36.91
$283.17
Revenue Next Year
$117.80
$340.98
P/E Ratio
N/A
N/A
Revenue Growth
45.98
1137.19
52 Week Low
$5.27
$1.54
52 Week High
$16.49
$8.70

Technical Indicators

Market Signals
Indicator
ENVX
NUVB
Relative Strength Index (RSI) 52.07 76.08
Support Level $7.27 $7.46
Resistance Level $7.90 $8.24
Average True Range (ATR) 0.55 0.62
MACD 0.26 0.13
Stochastic Oscillator 93.78 97.20

Price Performance

Historical Comparison
ENVX
NUVB

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: